Logo
  • OrganoBait
  • Horseshoe Crabs
  • Kepley K9
  • News
  • Advisory Board
  • Affiliates
  • Investor Updates
  • About
  • Contact
  • OrganoBait
  • Horseshoe Crabs
  • Kepley K9
  • News
  • Advisory Board
  • Affiliates
  • Investor Updates
  • About
  • Contact

Triad Startup Planning to Raise $1 Million for Manufacturing Facility

Home / News • Uncategorized / Triad Startup Planning to Rais …
June 14, 2015News, UncategorizedKBI, News

Link to the Gateway University Research Part article

Kepley Biosystems was recently featured in a write up in the Gateway University Research Park News detailing our research into the sustainable crustacean bait, Organobait, and our growth potential.

KBI featured in Triad Business Journal article
Kepley Biosystems Incorporated awarded NSF SBIR Phase 1B for ocean-restoring technology

Spread the word. Share this post!

Search Form

Recent Posts

Article: “Can Atomic-Scale Coatings Prevent SARS-CoV-2 Transmissions?” by Daphne AllenAug 20, 2020
Article: “Can farming horseshoe crabs help the COVID-19 Cause?” by Bonnie WaycottJul 17, 2020
Kepley BioSystems Files Second Accelerated Patent to Combat Coronavirus Epidemic Using Microbiocidal NanomaterialsJul 14, 2020
Kepley BioSystems Files Accelerated Patent for Novel Personal Protection Air Sterilization DeviceJun 18, 2020
Kepley BioSystems Addresses Horseshoe Crab Blood Testing Controversy and US Pharmacopoeia (USP) Endotoxin RegulationsJun 4, 2020

Recent Posts

Article: “Can Atomic-Scale Coatings Prevent SARS-CoV-2 Transmissions?” by Daphne Allen
Article: “Can farming horseshoe crabs help the COVID-19 Cause?” by Bonnie Waycott
Kepley BioSystems Files Second Accelerated Patent to Combat Coronavirus Epidemic Using Microbiocidal Nanomaterials

KBI Twitter

Like and Follow

RSS Feed
Follow by Email
Facebook
Facebook
Twitter
Visit Us
Follow Me
LinkedIn
LinkedIn
Share
YouTube
Instagram
  • Home
  • OrganoBait
  • HCRBI
  • Shorebird Initiative
  • News
  • Affiliates
  • Affiliated Scientists
  • Investors
  • About Us
  • Contact Us
© 2021 Kepley BioSystems Inc